These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36672151)

  • 1. Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8.
    Jin R; Zhou M; Lin F; Xu W; Xu A
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.
    Qi F; Liu F; Gao L
    Front Immunol; 2021; 12():790125. PubMed ID: 34868078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
    Emori T; Kasahara M; Sugahara S; Hashimoto M; Ito H; Narumiya S; Higashi Y; Fujii Y
    Eur J Pharmacol; 2020 Sep; 882():173238. PubMed ID: 32561292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
    Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
    J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects.
    Struyf S; Proost P; Vandercappellen J; Dempe S; Noyens B; Nelissen S; Gouwy M; Locati M; Opdenakker G; Dinsart C; Van Damme J
    Eur J Immunol; 2009 Mar; 39(3):843-57. PubMed ID: 19224633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo.
    Chang Y; Kang P; Cui T; Guo W; Zhang W; Du P; Yi X; Guo S; Gao T; Li C; Li S
    J Transl Med; 2023 Jul; 21(1):434. PubMed ID: 37403086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action Mechanism of Ethambutol Tablets on Pulmonary Tuberculosis Rat Model Based on Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway].
    Li JJ; Wu SF; Bai FX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):555-562. PubMed ID: 36065686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL6/sIL6R regulates TNFα-inflammatory response in synovial fibroblasts through modulation of transcriptional and post-transcriptional mechanisms.
    Valin A; Del Rey MJ; Municio C; Usategui A; Romero M; Fernández-Felipe J; Cañete JD; Blanco FJ; Ruano Y; Criado G; Pablos JL
    BMC Mol Cell Biol; 2020 Oct; 21(1):74. PubMed ID: 33126846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions.
    Li Y; Cui H; Li S; Li X; Guo H; Nandakumar KS; Li Z
    Int Immunopharmacol; 2023 Jan; 114():109585. PubMed ID: 36527884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGR1 Mediated Reduction of Fibroblast Secreted-TGF-β1 Exacerbated CD8
    Jin R; Xu H; Zhou M; Lin F; Xu W; Xu A
    Inflammation; 2024 Apr; 47(2):503-512. PubMed ID: 37880426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Janus Kinase Inhibitors: A Review of Their Application in the Vitiligo.
    Niu C; Xie H; Aisa HA
    Mini Rev Med Chem; 2021; 21(20):3203-3218. PubMed ID: 33823765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
    Seo SK; Seo DI; Park WS; Jung WK; Lee DS; Park SG; Choi JS; Kang MS; Choi YH; Choi I; Yu BC; Choi IW
    Life Sci; 2014 Sep; 112(1-2):82-9. PubMed ID: 25072357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.
    Harris JE; Harris TH; Weninger W; Wherry EJ; Hunter CA; Turka LA
    J Invest Dermatol; 2012 Jul; 132(7):1869-76. PubMed ID: 22297636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide Exerts Potential Anti-inflammatory Effect in Type 1 Diabetes by Inhibiting IFN-γ Production
    Zhao Y; Xie Y; Li W
    Endocr Metab Immune Disord Drug Targets; 2019; 19(5):656-664. PubMed ID: 30827273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The skin delivery of tofacitinib citrate using transethosomes and hybridized ethosomes/nanostructured lipid carriers for vitiligo therapy: Dermatopharmacokinetics and in vivo assays.
    Hesham H; Rady M; Hathout RM; Abdel-Halim M; Mansour S
    Int J Pharm; 2022 Dec; 629():122387. PubMed ID: 36375683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
    Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis.
    Harvey EJ; Li N; Ramji DP
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):806-12. PubMed ID: 17255531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomically distinct fibroblast subsets determine skin autoimmune patterns.
    Xu Z; Chen D; Hu Y; Jiang K; Huang H; Du Y; Wu W; Wang J; Sui J; Wang W; Zhang L; Li S; Li C; Yang Y; Chang J; Chen T
    Nature; 2022 Jan; 601(7891):118-124. PubMed ID: 34912121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK inhibitors in vitiligo: what they hit and what they miss - an immunopathogenesis based exposition of existing evidence.
    Sardana K; Muddebihal A; Khurana A
    Expert Rev Clin Pharmacol; 2023; 16(12):1221-1227. PubMed ID: 37982238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature.
    Relke N; Gooderham M
    J Cutan Med Surg; 2019; 23(3):298-306. PubMed ID: 30902022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.